0001213900-24-070034.txt : 20240816 0001213900-24-070034.hdr.sgml : 20240816 20240816103952 ACCESSION NUMBER: 0001213900-24-070034 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 EFFECTIVENESS DATE: 20240816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROONE MEDICAL TECHNOLOGIES Corp CENTRAL INDEX KEY: 0001500198 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270863354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521739 FILM NUMBER: 241214791 BUSINESS ADDRESS: STREET 1: 7599 ANAGRAM DR CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: (952) 426-1383 MAIL ADDRESS: STREET 1: 7599 ANAGRAM DR CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: Original Source Entertainment, Inc. DATE OF NAME CHANGE: 20100830 D 1 primary_doc.xml X0708 D LIVE 0001500198 NEUROONE MEDICAL TECHNOLOGIES Corp 7599 ANAGRAM DR EDEN PRAIRIE MN MINNESOTA 55344 (952) 426-1383 DELAWARE None Original Source Entertainment, Inc. Corporation true David A. Rosa 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Executive Officer Director Mark Christianson 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Executive Officer Ronald McClurg 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Executive Officer Steve Mertens 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Executive Officer Christopher Volker 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Executive Officer Edward Andrle 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Director Paul Buckman 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Director Jeffrey S. Mathiesen 7599 Anagram Dr Eden Prairie MN MINNESOTA 55344 Director Biotechnology Decline to Disclose 06b false 2024-08-02 false true true false 0 276043 276043 0 The offering amount excludes proceeds of up to $2,627,923 from warrant exercises, and a warrant to purchase 100,000 shares issued in connection with a loan and security agreement and proceeds of up to $66,000 from the exercise of such warrant. false 20 0 0 0 false NEUROONE MEDICAL TECHNOLOGIES Corp /s/ David A. Rosa David A. Rosa CEO and President 2024-08-16